PTHS PTHS Net product revenues — Total Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by PTHS in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTHS's net product revenues — total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is PTHS's net product revenues — total revenue?
- PTHS (PTHS) reported net product revenues — total revenue of $10.67M in Q1 2026.
- What does net product revenues — total revenue mean?
- This metric represents the total revenue generated from the sale of pharmaceutical products after accounting for returns, allowances, and rebates. It serves as a primary indicator of commercial traction and market adoption for the company's therapeutic portfolio. Tracking this figure allows investors to assess the transition from clinical-stage development to commercial-stage revenue generation.